Pre-launch market study
Why Are Indians Leaving Local Chemists?
We surveyed 150 urban Indian healthcare decision-makers before launch, and most want a chronic-medicine refill subscription. At ₹49 a month, 91.7% show positive intent, 82.6% are open to refills delivered three days before they run out, and 70.5% expect delivery within 12 hours. Guaranteed stock narrowly beats discounts as the top reason to subscribe.
Explore the findingsDefinitely (54.9%) or probably (36.8%) subscribe
Top-2-box openness to automated refills
Maximum acceptable delivery window
Based on 150 completed responses. Pre-launch market study.
What we set out to answer, and what we found
Can a chronic care refill subscription win urban medicine buyers, and what actually converts them?
Are people open to automated refills?
We asked how open people are to a monthly refill subscription that delivers chronic medicines three days before they run out.
Will people pay a monthly fee?
We tested intent to subscribe at ₹49 a month, bundled with 100% guaranteed stock and free pharmacist support.
What convinces them to subscribe, stock or price?
We asked buyers to rank guaranteed availability, a flat discount, doctor consultations and quarterly lab tests.
What friction and standards shape the decision?
We recorded spend by channel, pain points with offline chemists, trust factors such as authenticity, cold chain and pharmacist review, and acceptable delivery windows.
A ₹49 fee does not put people off. 91.7% show positive intent for automated monthly refills at ₹49 a month when bundled with guaranteed stock and pharmacist support (54.9% definitely, 36.8% probably). Outright rejection is just 2.1%.
Guaranteed stock edges out discounts. Guaranteed availability of exact prescribed brands has the best mean rank (1.40) and the largest first-choice share (50.0%), against 45.1% for a flat 20% discount. Doctor consultations (2.8%) and home lab tests (2.1%) are rarely anyone's first choice.
Buyers are ready for automatic refills. Deliveries scheduled three days before medicines run out earned 82.6% top-2-box openness, and fewer than 5% pushed back.
Visiting several chemists is the opening. 47.9% say having to visit multiple chemists to complete one prescription is a major frustration, and only 1.4% report no issues with local chemists.
Fast delivery is a must. Even for predictable monthly refills, 70.5% want delivery within 12 hours (34.2% within 2 to 4 hours), and 52% of definite subscribers expect 2 to 4 hours.
Caregivers and pharmacist advice matter for households. 77% of joint decision-makers manage chronic medicines for dependents, which argues for multi-profile family accounts. 12% of majority-online spenders cite a lack of qualified pharmacist guidance as a barrier.
Chemist Hopping
Must visit several shops for one prescription
82.6% Are Open to Automated Refills Delivered Three Days Early
Openness to an Automated Monthly Refill Delivered Three Days Before You Run Out
Base: 144 respondents, rating 1 to 5
View the data behind this chart
| Answer | Share |
|---|---|
| 5 (very open) | 32.6% |
| 4 | 50% |
| 3 | 12.5% |
| 2 | 3.47% |
| 1 (not open) | 1.39% |
01. 50.0% rated their openness a 4 and 32.6% a 5, which makes an 82.6% top-2-box. Fewer than 5% pushed back (ratings 1 or 2).
02. Openness is highest among 36 to 45 year olds at 90.0% top-2-box (58.0% rating 4, 32.0% rating 5).
03. The 46 to 55 cohort sits 17.2 points lower at 72.8% (45.5% rating 4, 27.3% rating 5), so older buyers may need more reassurance or personal contact before they adopt automated refills.
A ₹49 Monthly Fee Has Strong Viability: 91.7% Positive Intent
Would You Subscribe if the Monthly Service and Delivery Fee Were ₹49?
With 100% guaranteed stock and free pharmacist support. Base: 144 respondents
View the data behind this chart
| Answer | Share |
|---|---|
| Yes, would definitely subscribe | 54.9% |
| Yes, would probably subscribe | 36.8% |
| No, only with different delivery terms | 6.3% |
| No, not interested in a subscription | 2.1% |
01. 54.9% would definitely subscribe and 36.8% probably would, a combined 91.7%. Only 2.1% reject it outright.
02. Definite intent rises with age, from 42.9% among 25 to 35 year olds to 62.0% among 36 to 45 year olds and 66.7% among 46 to 55 year olds. That is a 23.8-point gap between the youngest and oldest of these groups.
03. Among 25 to 35 year olds, 48.2% say “probably”. This group is less committed and may need trial offers or onboarding incentives.
Guaranteed Stock Is the Leading Reason to Subscribe, Narrowly Ahead of Discounts
Which Benefit Would Convince You to Subscribe? (Borda Score)
Base: 144 respondents, ranked; higher score = stronger
View the data behind this chart
| Answer | Value |
|---|---|
| Guaranteed 100% stock of my exact prescribed brands | 207 |
| Flat 20% extra discount vs local chemist prices | 194 |
| Free monthly doctor phone consultation and renewal | 99 |
| Free quarterly home sample collection for blood tests | 83 |
01. Guaranteed stock has the best mean rank (1.40) and the largest first-choice share (50.0%). A flat 20% discount is close behind (mean rank 1.59, 45.1% first choice) and is slightly more often in the top three (65.3% against 63.9%).
02. Bundled services rarely decide it. Doctor consultations take 2.8% of first choices and home lab-test collection 2.1%.
03. Younger buyers care more about price. Among 25 to 35 year olds, 53.6% ranked the discount first (average rank 1.38) against 42.9% for the stock guarantee.
04. The last stockout shapes the answer. People who hopped between chemists during their last stockout cite guaranteed stock 38 times against 21 for discounts, while those who switched to an e-pharmacy app chose the discount (50) over stock (32).
E-Pharmacies Reach 92.5% of Buyers, but Spend Stays Split Across Channels
Share of Quarterly Medicine Spend by Channel
Base: 146 respondents; share of buyers in each spend band
View the data behind this chart
| E-pharmacies | Quick-commerce apps | Local retail chemists | |
|---|---|---|---|
| Majority share (50 to 100%) | 47.3% | 37% | 22.6% |
| Minority share (1 to 49%) | 45.2% | 49.3% | 71.9% |
| No spend (0%) | 7.5% | 13.7% | 5.5% |
01. Only 7.5% (n=11) spend nothing at e-pharmacies. 47.3% (n=69) give them a majority of their spend, and an almost identical 45.2% (n=66) give them only a minority share.
02. Local chemists still hold ground. 94.5% spend something there, 71.9% (n=105) keep a residual 1 to 49% and 22.6% (n=33) still send them the majority of spend. Only 5.5% have dropped them entirely.
03. Quick-commerce takes a majority share for 37.0% of buyers, while 13.7% do not use fast-delivery apps at all.
04. Older buyers use e-pharmacies more: 50.0% of 46 to 55 year olds give e-pharmacies a majority share, against 44.6% of 25 to 35 year olds (50.0% of whom keep e-pharmacies to a minority share).
47.9% Cite Multi-Store Hopping as a Chemist Pain Point
Biggest Frustrations When Buying Medicines From Local Chemists
Base: 146 respondents, multi-select (average 2.23 selected)
View the data behind this chart
| Answer | Share |
|---|---|
| Having to visit multiple shops for one prescription | 47.9% |
| Lack of discounts or competitive pricing | 45.9% |
| Lack of qualified pharmacist guidance | 44.5% |
| Inconvenience of travel and waiting lines | 43.8% |
| Stockouts of specific brands or dosages | 39.7% |
| No friction with local chemists | 1.4% |
01. Only 1.4% report no issues, and respondents cite 2.23 pain points on average. Store hopping (47.9%), lack of discounts (45.9%) and lack of qualified guidance (44.5%) lead.
02. Problems come together. 26.71% face both store hopping and travel delays, and 60.9% of those with travel friction also have to visit multiple shops. 60.3% of those hit by stockouts also hop between stores.
03. Among people highly open to automated refills (rating 4 or 5), store hopping is the most-cited chemist pain point (60 selections), ahead of pharmacist guidance gaps (56) and travel and waiting (55).
Authenticity, Cold Chain and Pharmacist Review Are Table Stakes
Importance of Trust Factors When Choosing Where to Buy Chronic Medicines
Base: 144 respondents
View the data behind this chart
| Very important | Somewhat important | Not important | |
|---|---|---|---|
| 100% genuine medicine guarantee | 36.1% | 61.1% | 2.8% |
| Cold chain for temperature-sensitive medicines | 50.7% | 41.7% | 7.6% |
| Dedicated pharmacist to review prescriptions | 48.6% | 45.1% | 6.3% |
01. 97.2% rate a 100% genuine medicine guarantee as important (36.1% very, 61.1% somewhat). Buyers treat it as a basic requirement, and a premium add-on would not earn credit for it.
02. Cold chain has the strongest “very important” score at 50.7% (92.4% important overall). Dedicated pharmacist review has the highest overall importance at 93.8% (48.6% very).
03. Strength of feeling varies. 42.0% of 36 to 45 year olds rate authenticity very important against 33.9% of 25 to 35 year olds, and 39.6% of primary decision-makers against 27.9% of joint decision-makers.
04. Among buyers who send the majority of their spend online, 12% cite a lack of qualified pharmacist guidance and prescription checking as a key barrier.
70.5% Want Even Scheduled Refills Delivered Within 12 Hours
Maximum Acceptable Delivery Window for Recurring Monthly Refills
Base: 146 respondents, single choice
View the data behind this chart
| Answer | Share |
|---|---|
| Within 2 to 4 hours | 34.2% |
| Same day (within 12 hours) | 36.3% |
| Next day (within 24 hours) | 21.9% |
| Within 2 to 3 days | 6.2% |
| Timing does not matter | 1.4% |
01. 36.3% expect same-day delivery within 12 hours and 34.2% want delivery within 2 to 4 hours, so over 7 in 10 need same-day turnaround even for scheduled medicines.
02. Only 1.4% say timing does not matter under automated scheduling, and 52% of definite subscribers expect delivery within 2 to 4 hours.
Self-Managers and Family Caregivers Are Both Highly Receptive
Openness to Automated Refills (Rating 4 or 5) by Who the Medicines Are For
Self: 53 of 61; family or dependents: 53 of 67 (directional bases)
View the data behind this chart
| Answer | Share |
|---|---|
| Chronic medicines for self | 87% |
| Chronic medicines for family or dependents | 79% |
01. Self-managers average 4.21 out of 5 on refill openness, against 4.00 for family caregivers.
02. 77% of joint healthcare decision-makers manage chronic medicines for dependents or family members.
03. A stockout makes people more open: 87% of those who switched to an e-pharmacy app during their last stockout (55 of 63) and 77% of those who visited several chemists (34 of 44) rate automated refills 4 or 5.
What we would recommend
Practical priorities drawn from this study for further validation.
Launch ₹49 a month as the main entry tier.
91.7% show positive intent at ₹49 a month (54.9% definite, 36.8% probable), with outright rejection at 2.1%. Make it the standard tier to get the most sign-ups and steady recurring revenue.
Lead acquisition with stock certainty.
Guaranteed stock of exact prescribed brands is the top-ranked reason to subscribe (50.0% first choice). Promise complete-basket delivery to the 47.9% frustrated by hopping between chemists, and keep the discount as a supporting offer for price-led e-pharmacy users.
Make the three-day buffer the default refill cycle.
Since 82.6% are open to automated deliveries three days before medicines run out, set auto-refill to trigger at the three-day mark by default.
Build fast local dispatch.
70.5% want delivery within 12 hours and 52% of definite subscribers expect 2 to 4 hours. Favour local inventory points over central warehouses with multi-day shipping.
